Showing 1 posts of 1 posts found.
Gilead’s dominance of the hepatitis C market is under severe threat after a federal jury ruled in favour of MSD …
How chronic disease creates opportunity on diagnostic and therapeutic pipelines
EnteroBiotix appoints former GSK Chief Medical Officer to board
Stryker invests US$400m in CMR Surgical and secures option to acquire business
AI: an early warning system for patient safety
Tezspire improves symptoms and tissue inflammation in phase 3 EoE trial